An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

Study Identifier
MAF/AGN/NS/OAB/002
CT.gov Identifier
NCT02161159
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Bladder Disorder - Overactive Bladder
    • Study Drug
  • botulinum toxin Type A
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * No prior treatment with botulinum toxin Type A for treatment of iOAB
    Exclusion Criteria:
    * Treatment with any botulinum toxin Type A within 18 months

    Protocol Summary

    This study will evaluate real world pattern of use of BOTOX® in actual clinical practice in patients with idiopathic overactive bladder (iOAB) with urinary incontinence whose symptoms have not been adequately managed by oral anticholinergic therapy.

    Study Locations

    Location
    Status
    Location
    David Brix
    Bad Mergentheim, Germany, 97980
    Status
    Not applicable
    Location
    Urologie Turmschtraße
    Berlin, Germany, 10551
    Status
    Not applicable
    Location
    Uwe-Carsten
    Berlin, Germany, 12099
    Status
    Not applicable
    Location
    Albrecht Kastein
    Berlin, Germany, 12247
    Status
    Not applicable
    Location
    ATURO
    Berlin, Germany, 14197
    Status
    Not applicable
    Location
    MVZ Burgdorf
    Burgdorf, Hanover, Germany, 31303
    Status
    Not applicable
    Showing {first} - {last} of {total} Results